Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
is a newer topical agent of pleuromutilin class approved by the Food and Drug Administration for treatment of impetigo in children
FMS-like tyrosine kinase 3
It has excellent selectivity for Cdc42 with no inhibition toward Rho and Rac in the same GTPase family
Smiles: N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)C1=CC=NC2=CC=C(C=C21)OCCCN1CCN(CC1)C(=O)CN(CC1=NC=CN1CC(=O)N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O)CC1=NC=CN1CC(=O)N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O
3-dihydrobenzo[f][1
E3330 Catalog No.:M20512-C is a newer topical agentE3330 (APX 3330) is a direct, orally active and selective AP endonuclease 1 (APE1; REF 1) inhibitor, which suppresses NF B DNA binding activity. E3330 (APX 3330) blocks TNF induced activation of IL 8 production in liver cancer cell lines. E3330 (APX 3330) shows anticancer properties, such as inhibition of cancer cell growth and migration. Product information CAS Number: 136164 66 4 Molecular Weight: 378. 46 Formula: C21H30O6 Chemical Name: (2E) 2